Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
New England Journal of Medicine · 07.11.2024 · 391 (18) · 1709-1720
DOI: 10.1056/nejmoa2404139 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 07.11.2024. Verfasst von Georgina V Long und 22 weiteren Autor:innen. Beteiligte Einrichtung: From the Melanoma Institute Australia, the University of Sydney, Royal North Shore Hospital, and Mater Hospital, Sydney (G.V.L.), Princess Alexandra …. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Imidazoles, Melanoma, Oximes. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Novartis Pharma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Melanoma Institute Australia, the University of Sydney, Royal North Shore Hospital, and Mater Hospital, Sydney (G.V.L.), Princess Alexandra Hospital, the Gallipoli Medical Research Foundation, and the Universit…
ORCID-Profile: Georgina V Long, Dirk Schadendorf
Förderung
- Novartis Pharma
Zitieren
APA
Long, G. V., Hauschild, A., Santinami, M., Kirkwood, J. M., Atkinson, V., Mandala, M., Merelli, B., Sileni, V. C., Nyakas, M., Haydon, A., Dutriaux, C., Robert, C., Mortier, L., Schachter, J., Schadendorf, D., Lesimple, T., Plummer, R., Larkin, J., Tan, M., …, & Dummer, R. (2024). Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. New England Journal of Medicine, 391(18), 1709-1720. https://doi.org/10.1056/nejmoa2404139
Vancouver
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, et al. Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. New England Journal of Medicine. 2024;391(18):1709-1720. doi:10.1056/nejmoa2404139
BibTeX
@article{Long2024,
author = {Long, Georgina V and Hauschild, Axel and Santinami, Mario and Kirkwood, John M and Atkinson, Victoria and Mandala, Mario and Merelli, Barbara and Sileni, Vanna Chiarion and Nyakas, Marta and Haydon, Andrew and Dutriaux, Caroline and Robert, Caroline and Mortier, Laurent and Schachter, Jacob and Schadendorf, Dirk and Lesimple, Thierry and Plummer, Ruth and Larkin, James and Tan, Monique and Adnaik, Sachin Bajirao and Burgess, Paul and Jandoo, Tarveen and Dummer, Reinhard},
title = {Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {18},
pages = {1709--1720},
doi = {10.1056/nejmoa2404139}
}
EUVIMED